MicroRNA-mediated posttranscriptional mechanisms of gene expression in proliferating and quiescent cancer cells

RNA Biology

Volumn 9, Issue 6, 2012, Pages 871-880

  LeTonqueze, Olivier ^a   Lee, Ju Huck ^a   Vasudevan, Shobha ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer; MicroRNA; Quiescence; Regulation; RNA binding proteins

Indexed keywords

MESSENGER RNA; MICRORNA; RNA BINDING PROTEIN;

3' UNTRANSLATED REGION; ADENYLATION; CANCER CELL; CANCER RECURRENCE; CANCER RESISTANCE; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL CYCLE REGULATION; CELL DENSITY; CELL HETEROGENEITY; CELL PROLIFERATION; CELLULAR STRESS SIGNAL; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSCRIPTION; POSTTRANSCRIPTIONAL GENE EXPRESSION; PROTEIN RNA BINDING; REVIEW; RNA STABILITY; RNA TRANSLATION; TRANSLATION REGULATION; TUMOR GROWTH; UPREGULATION;

EID: 84863499887     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.20806     Document Type: Review

References (149)

1. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006; 20:515-24; PMID:16510870; http://dx.doi.org/10.1101/gad.1399806.
2. Ivey KN, Srivastava D. MicroRNAs as regulators of differentiation and cell fate decisions. Cell Stem Cell 2010; 7:36-41; PMID:20621048; http://dx.doi.org/10.1016/j.stem.2010.06.012.
3. Munker R, Calin GA. MicroRNA profiling in cancer. Clin Sci (Lond) 2011; 121:141-58; PMID:21526983; http://dx.doi.org/10.1042/CS20110005.
4. Subramanyam D, Blelloch R. From microRNAs to targets: pathway discovery in cell fate transitions. Curr Opin Genet Dev 2011; 21:498-503; PMID:21636265; http://dx.doi.org/10.1016/j.gde.2011.04.011.
5. Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011; 11:849-64; PMID:22113163; http://dx.doi.org/10.1038/ nrc3166.
6. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-33; PMID:19167326; http://dx.doi.org/10.1016/j.cell.2009.01.002.
7. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006; 94:776-80; PMID:16495913; http://dx.doi.org/10. 1038/sj.bjc.6603023.
8. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS. Non-coding RNAs: regulators of disease. J Pathol 2010; 220:126-39; PMID:19882673; http://dx.doi.org/10.1002/path.2638.
9. Le Quesne JP, Spriggs KA, Bushell M, Willis AE. Dysregulation of protein synthesis and disease. J Pathol 2010; 220:140-51; PMID:19827082.
10. Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol 2011; 223:102-15; PMID:21125669; http://dx.doi.org/10.1002/path.2806.
11. Nana-Sinkam SP, Croce CM. MicroRNAs as therapeutic targets in cancer. Transl Res 2011; 157:216-25; PMID:21420032; http://dx.doi.org/10.1016/j.trsl. 2011.01.013.
12. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002; 99:15524-9; PMID:12434020; http://dx.doi.org/10.1073/pnas.242606799.
13. Conkrite K, Sundby M, Mukai S, Thomson JM, Mu D, Hammond SM, et al. miR-17-92 cooperates with RB pathway mutations to promote retinoblastoma. Genes Dev 2011; 25:1734-45; PMID:21816922; http://dx.doi.org/10.1101/gad.17027411.
14. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435:839-43; PMID:15944709; http://dx.doi.org/10.1038/nature03677.
15. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev 2009; 23:2839-49; PMID:20008935; http://dx.doi.org/10.1101/gad.1861409.
16. Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J, et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 2008; 9:405-14; PMID:18327259; http://dx.doi.org/10.1038/ni1575.
17. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008; 132:875-86; PMID:18329372; http://dx.doi.org/10.1016/j.cell.2008.02.019.
18. Zoon CK, Starker EQ, Wilson AM, Emmert-Buck MR, Libutti SK, Tangrea MA. Current molecular diagnostics of breast cancer and the potential incorporation of microRNA. Expert Rev Mol Diagn 2009; 9:455-67; PMID:19580430; http://dx.doi.org/10.1586/erm.09.25.
19. Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 2009; 11:1143-9; PMID:19684575; http://dx.doi.org/10. 1038/ncb1929.
20. Lee YS, Pressman S, Andress AP, Kim K, White JL, Cassidy JJ, et al. Silencing by small RNAs is linked to endosomal trafficking. Nat Cell Biol 2009; 11:1150-6; PMID:19684574; http://dx.doi.org/10.1038/ncb1930.
21. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids - the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011; 8:467-77; PMID:21647195; http://dx.doi.org/10.1038/nrclinonc.2011. 76.
22. Li L, Bhatia R. Stem cell quiescence. Clin Cancer Res 2011; 17:4936-41; PMID:21593194; http://dx.doi.org/10.1158/1078-0432.CCR-10-1499.
23. Lindeman GJ, Visvader JE. Insights into the cell of origin in breast cancer and breast cancer stem cells. Asia Pac J Clin Oncol 2010; 6:89-97; PMID:20565420; http://dx.doi.org/10.1111/j.1743-7563.2010.01279.x.
24. Nicholson E, Holyoake T. The chronic myeloid leukemia stem cell. Clin Lymphoma Myeloma 2009; 9(Suppl 4):S376-81; PMID:20007106; http://dx.doi.org/10. 3816/CLM.2009.s.037.
25. Besançon R, Valsesia-Wittmann S, Puisieux A, Caron de Fromentel C, Maguer-Satta V. Cancer stem cells: the emerging challenge of drug targeting. Curr Med Chem 2009; 16:394-416; PMID:19199913; http://dx.doi.org/10.2174/ 092986709787315531.
26. Coller HA, Sang L, Roberts JM. A new description of cellular quiescence. PLoS Biol 2006; 4:e83; PMID:16509772; http://dx.doi.org/10.1371/journal.pbio. 0040083.
27. Sang L, Coller HA, Roberts JM. Control of the reversibility of cellular quiescence by the transcriptional repressor HES1. Science 2008; 321:1095-100; PMID:18719287; http://dx.doi.org/10.1126/science.1155998.
28. Tavaluc RT, Hart LS, Dicker DT, El-Deiry WS. Effects of low confluency, serum starvation and hypoxia on the side population of cancer cell lines. Cell Cycle 2007; 6:2554-62; PMID:17912032; http://dx.doi.org/10.4161/cc.6.20.4911.
29. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013.
30. Zheng X, Seshire A, Rüster B, Bug G, Beissert T, Puccetti E, et al. Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells. Haematologica 2007; 92:323-31; PMID:17339181; http://dx.doi.org/10.3324/haematol.10541.
31. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009; 138:645-59; PMID:19682730; http://dx.doi.org/10.1016/j. cell.2009.06.034.
32. Dey-Guha I, Wolfer A, Yeh AC, G Albeck J, Darp R, Leon E, et al. Asymmetric cancer cell division regulated by AKT. Proc Natl Acad Sci U S A 2011; 108:12845-50; PMID:21757645; http://dx.doi.org/10.1073/pnas.1109632108.
33. Pantel K, Alix-Panabières C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol 2009; 6:339-51; PMID:19399023; http://dx.doi.org/10.1038/ nrclinonc.2009.44.
34. Riethdorf S, Wikman H, Pantel K. Review: Biological relevance of disseminated tumor cells in cancer patients. Int J Cancer 2008; 123:1991-2006; PMID:18712708; http://dx.doi.org/10.1002/ijc.23825.
35. Yu M, Stott S, Toner M, Maheswaran S, Haber DA. Circulating tumor cells: approaches to isolation and characterization. J Cell Biol 2011; 192:373-82; PMID:21300848; http://dx.doi.org/10.1083/jcb.201010021.
36. Qian B, Deng Y, Im JH, Muschel RJ, Zou Y, Li J, et al. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One 2009; 4:e6562; PMID:19668347; http://dx.doi.org/10.1371/journal.pone.0006562.
37. Prewitt TW, Matthews W, Chaudhri G, Pogrebniak HW, Pass HI. Tumor necrosis factor induces doxorubicin resistance to lung cancer cells in vitro. J Thorac Cardiovasc Surg 1994; 107:43-9; PMID:8283917.
38. Jinushi M, Chiba S, Yoshiyama H, Masutomi K, Kinoshita I, Dosaka-Akita H, et al. Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells. Proc Natl Acad Sci U S A 2011; 108:12425-30; PMID:21746895; http://dx.doi.org/10.1073/pnas.1106645108.
39. Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends Immunol 2012; 33:119-26; PMID:22277903; http://dx.doi.org/10.1016/j.it.2011.12.001.
40. Dirkx AE, Oude Egbrink MG, Wagstaff J, Griffioen AW. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. J Leukoc Biol 2006; 80:1183-96; PMID:16997855; http://dx.doi.org/10.1189/jlb.0905495.
41. Laoui D, Movahedi K, Van Overmeire E, Van den Bossche J, Schouppe E, Mommer C, et al. Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions. Int J Dev Biol 2011; 55:861-7; PMID:22161841; http://dx.doi.org/10.1387/ijdb.113371dl.
42. Blomen VA, Boonstra J. Cell fate determination during G1 phase progression. Cell Mol Life Sci 2007; 64:3084-104; PMID:17891333; http://dx.doi.org/10.1007/s00018-007-7271-z.
43. Friedman DL. Role of cyclic nucleotides in cell growth and differentiation. Physiol Rev 1976; 56:652-708; PMID:185633.
44. Schorl C, Sedivy JM. Analysis of cell cycle phases and progression in cultured mammalian cells. Methods 2007; 41:143-50; PMID:17189856; http://dx.doi.org/10.1016/j.ymeth.2006.07.022.
45. Hwang HW, Wentzel EA, Mendell JT. Cell-cell contact globally activates microRNA biogenesis. Proc Natl Acad Sci U S A 2009; 106:7016-21; PMID:19359480; http://dx.doi.org/10.1073/pnas.0811523106.
46. Vasudevan S, Steitz JA. AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell 2007; 128:1105-18; PMID:17382880; http://dx.doi.org/10.1016/j.cell.2007.01.038.
47. Vasudevan S, Tong Y, Steitz JA. Cell-cycle control of microRNA-mediated translation regulation. Cell Cycle 2008; 7:1545-9; PMID:18469529; http://dx.doi.org/10.4161/cc.7.11.6018.
48. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007; 318:1931-4; PMID:18048652; http://dx.doi.org/10.1126/science.1149460.
49. Mortensen RD, Serra M, Steitz JA, Vasudevan S. Posttranscriptional activation of gene expression in Xenopus laevis oocytes by microRNA-protein complexes (microRNPs). Proc Natl Acad Sci U S A 2011; 108:8281-6; PMID:21536868; http://dx.doi.org/10.1073/pnas.1105401108.
50. Cheung TH, Quach NL, Charville GW, Liu L, Park L, Edalati A, et al. Maintenance of muscle stem-cell quiescence by microRNA-489. Nature 2012; 482:524-8; PMID:22358842; http://dx.doi.org/10.1038/nature10834.
51. Li R, Qian N, Tao K, You N, Wang X, Dou K. MicroRNAs involved in neoplastic transformation of liver cancer stem cells. J Exp Clin Cancer Res 2010; 29:169; PMID:21176238; http://dx.doi.org/10.1186/1756-9966-29-169.
52. Nagata Y, Maesawa C, Tada H, Takikawa Y, Yashima-Abo A, Masuda T. Differential microRNA expression between bone marrow side population cells and hepatocytes in adult mice. Int J Mol Med 2009; 24:35-43; PMID:19513532.
53. Misawa A, Katayama R, Koike S, Tomida A, Watanabe T, Fujita N. AP-1-Dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP cells. Oncol Res 2010; 19:23-33; PMID:21141738; http://dx.doi.org/10.3727/096504010X12828372551759.
54. Lemons JM, Feng XJ, Bennett BD, Legesse-Miller A, Johnson EL, Raitman I, et al. Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol 2010; 8:e1000514; PMID:21049082; http://dx.doi.org/10.1371/journal.pbio.1000514.
55. Wang F, Xue X, Wei J, An Y, Yao J, Cai H, et al. hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. Br J Cancer 2010; 103:567-74; PMID:20628378; http://dx.doi.org/10.1038/sj.bjc.6605724.
56. Sandberg R, Neilson JR, Sarma A, Sharp PA, Burge CB. Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites. Science 2008; 320:1643-7; PMID:18566288; http://dx.doi.org/10. 1126/science.1155390.
57. Kedde M, van Kouwenhove M, Zwart W, Oude Vrielink JA, Elkon R, Agami R. A Pumilio-induced RNA structure switch in p27-3′ UTR controls miR-221 and miR-222 accessibility. Nat Cell Biol 2010; 12:1014-20; PMID:20818387; http://dx.doi.org/10.1038/ncb2105.
58. Espel E. The role of the AU-rich elements of mRNAs in controlling translation. Semin Cell Dev Biol 2005; 16:59-67; PMID:15659340; http://dx.doi.org/10.1016/j.semcdb.2004.11.008.
59. Sirenko O, Böcker U, Morris JS, Haskill JS, Watson JM. IL-1 beta transcript stability in monocytes is linked to cytoskeletal reorganization and the availability of mRNA degradation factors. Immunol Cell Biol 2002; 80:328-39; PMID:12121221; http://dx.doi.org/10.1046/j.1440-1711.2002.01085.x.
60. Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007; 21:1025-30; PMID:17437991; http://dx.doi.org/10.1101/ gad.1540407.
61. Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007; 315:1576-9; PMID:17322030; http://dx.doi.org/10.1126/science.1137999.
62. Mayr C, Bartel DP. Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009; 138:673-84; PMID:19703394; http://dx.doi.org/10.1016/j.cell.2009.06.016.
63. Di Giammartino DC, Nishida K, Manley JL. Mechanisms and consequences of alternative polyadenylation. Mol Cell 2011; 43:853-66; PMID:21925375; http://dx.doi.org/10.1016/j.molcel.2011.08.017.
64. Ji Z, Tian B. Reprogramming of 3¢ untranslated regions of mRNAs by alternative polyadenylation in generation of pluripotent stem cells from different cell types. PLoS One 2009; 4:e8419; PMID:20037631; http://dx.doi.org/10.1371/journal.pone.0008419.
65. To KK, Zhan Z, Litman T, Bates SE. Regulation of ABCG2 expression at the 3¢ untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line. Mol Cell Biol 2008; 28:5147-61; PMID:18573883; http://dx.doi.org/10. 1128/MCB.00331-08.
66. Newman MA, Hammond SM. Emerging paradigms of regulated microRNA processing. Genes Dev 2010; 24:1086-92; PMID:20516194; http://dx.doi.org/10. 1101/gad.1919710.
67. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009; 10:126-39; PMID:19165215; http://dx.doi.org/10.1038/nrm2632.
68. Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res 2005; 65:3509-12; PMID:15867338; http://dx.doi.org/10.1158/0008-5472.CAN-05- 0298.
69. Carthew RW, Sontheimer EJ. Origins and Mechanisms of miRNAs and siRNAs. Cell 2009; 136:642-55; PMID:19239886; http://dx.doi.org/10.1016/j.cell.2009.01. 035.
70. Winter J, Diederichs S. MicroRNA biogenesis and cancer. Methods Mol Biol 2011; 676:3-22; PMID:20931386; http://dx.doi.org/10.1007/978-1-60761-863-8-1.
71. Michlewski G, Cáceres JF. Antagonistic role of hnRNP A1 and KSRP in the regulation of let-7a biogenesis. Nat Struct Mol Biol 2010; 17:1011-8; PMID:20639884; http://dx.doi.org/10.1038/nsmb.1874.
72. Trabucchi M, Briata P, Garcia-Mayoral M, Haase AD, Filipowicz W, Ramos A, et al. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 2009; 459:1010-4; PMID:19458619; http://dx.doi.org/10.1038/ nature08025.
73. Van Wynsberghe PM, Kai ZS, Massirer KB, Burton VH, Yeo GW, Pasquinelli AE. LIN-28 co-transcriptionally binds primary let-7 to regulate miRNA maturation in Caenorhabditis elegans. Nat Struct Mol Biol 2011; 18:302-8; PMID:21297634; http://dx.doi.org/10.1038/nsmb.1986.
74. Arasu P, Wightman B, Ruvkun G. Temporal regulation of lin-14 by the antagonistic action of two other heterochronic genes, lin-4 and lin-28. Genes Dev 1991; 5:1825-33; PMID:1916265; http://dx.doi.org/10.1101/gad.5.10.1825.
75. Newman MA, Hammond SM. Lin-28: an early embryonic sentinel that blocks Let-7 biogenesis. Int J Biochem Cell Biol 2010; 42:1330-3; PMID:20619222; http://dx.doi.org/10.1016/j.biocel.2009.02.023.
76. Hagan JP, Piskounova E, Gregory RI. Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Nat Struct Mol Biol 2009; 16:1021-5; PMID:19713958; http://dx.doi.org/10.1038/nsmb.1676.
77. Viswanathan SR, Daley GQ, Gregory RI. Selective blockade of microRNA processing by Lin28. Science 2008; 320:97-100; PMID:18292307; http://dx.doi.org/10.1126/science.1154040.
78. Lehrbach NJ, Armisen J, Lightfoot HL, Murfitt KJ, Bugaut A, Balasubramanian S, et al. LIN-28 and the poly(U) polymerase PUP-2 regulate let-7 microRNA processing in Caenorhabditis elegans. Nat Struct Mol Biol 2009; 16:1016-20; PMID:19713957; http://dx.doi.org/10.1038/nsmb.1675.
79. Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, Dews M, et al. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci U S A 2009; 106:3384-9; PMID:19211792; http://dx.doi.org/10.1073/pnas.0808300106.
80. Heo I, Joo C, Cho J, Ha M, Han J, Kim VN. Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell 2008; 32:276-84; PMID:18951094; http://dx.doi.org/10.1016/j.molcel.2008.09.014.
81. Piskounova E, Polytarchou C, Thornton JE, LaPierre RJ, Pothoulakis C, Hagan JP, et al. Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms. Cell 2011; 147:1066-79; PMID:22118463; http://dx.doi.org/10.1016/j. cell.2011.10.039.
82. Lee JY, Moon HJ, Lee WK, Chun HJ, Han CW, Jeon YW, et al. Merlin facilitates ubiquitination and degradation of transactivation-responsive RNA-binding protein. Oncogene 2006; 25:1143-52; PMID:16247459; http://dx.doi.org/10.1038/sj.onc.1209150.
83. Kim YK, Yeo J, Ha M, Kim B, Kim VN. Cell adhesion-dependent control of microRNA decay. Mol Cell 2011; 43:1005-14; PMID:21925388; http://dx.doi.org/10. 1016/j.molcel.2011.07.031.
84. Rissland OS, Hong SJ, Bartel DP. MicroRNA destabilization enables dynamic regulation of the miR-16 family in response to cell-cycle changes. Mol Cell 2011; 43:993-1004; PMID:21925387; http://dx.doi.org/10.1016/j.molcel.2011.08. 021.
85. Gruber JJ, Zatechka DS, Sabin LR, Yong J, Lum JJ, Kong M, et al. Ars2 links the nuclear cap-binding complex to RNA interference and cell proliferation. Cell 2009; 138:328-39; PMID:19632182; http://dx.doi.org/10.1016/ j.cell.2009.04.046.
86. Kumar MS, Pester RE, Chen CY, Lane K, Chin C, Lu J, et al. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev 2009; 23:2700-4; PMID:19903759; http://dx.doi.org/10.1101/gad.1848209.
87. Melo SA, Moutinho C, Ropero S, Calin GA, Rossi S, Spizzo R, et al. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 2010; 18:303-15; PMID:20951941; http://dx.doi.org/10.1016/j. ccr.2010.09.007.
88. Rotunno M, Zhao Y, Bergen AW, Koshiol J, Burdette L, Rubagotti M, et al. Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival. Br J Cancer 2010; 103:1870-4; PMID:21102586; http://dx.doi.org/10.1038/sj.bjc.6605976.
89. Vasudevan S. [Wiley Interdiscip Rev RNA. ]. Posttranscriptional Upregulation by MicroRNAs. 2011; 2011.
90. Tserel L, Runnel T, Kisand K, Pihlap M, Bakhoff L, Kolde R, et al. MicroRNA expression profiles of human blood monocyte-derived dendritic cells and macrophages reveal miR-511 as putative positive regulator of Toll-like receptor 4. J Biol Chem 2011; 286:26487-95; PMID:21646346; http://dx.doi.org/10.1074/ jbc.M110.213561.
91. Mukherji S, Ebert MS, Zheng GX, Tsang JS, Sharp PA, van Oudenaarden A. MicroRNAs can generate thresholds in target gene expression. Nat Genet 2011; 43:854-9; PMID:21857679; http://dx.doi.org/10.1038/ng.905.
92. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004; 305:1437-41; PMID:15284456; http://dx.doi.org/10.1126/science.1102513.
93. Wu L, Fan J, Belasco JG. Importance of translation and nonnucleolytic ago proteins for on-target RNA interference. Curr Biol 2008; 18:1327-32; PMID:18771919; http://dx.doi.org/10.1016/j.cub.2008.07.072.
94. Giraldez AJ, Mishima Y, Rihel J, Grocock RJ, Van Dongen S, Inoue K, et al. Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs. Science 2006; 312:75-9; PMID:16484454; http://dx.doi.org/10.1126/science. 1122689.
95. Wu L, Fan J, Belasco JG. MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci U S A 2006; 103:4034-9; PMID:16495412; http://dx.doi.org/10. 1073/pnas.0510928103.
96. Chekulaeva M, Filipowicz W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 2009; 21:452-60; PMID:19450959; http://dx.doi.org/10.1016/j.ceb.2009.04.009.
97. Fabian MR, Sundermeier TR, Sonenberg N. Understanding how miRNAs post-transcriptionally regulate gene expression. Prog Mol Subcell Biol 2010; 50:1-20; PMID:19841878; http://dx.doi.org/10.1007/978-3-642-03103-8-1.
98. Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004; 304:594-6; PMID:15105502; http://dx.doi.org/10.1126/science. 1097434.
99. Beilharz TH, Humphreys DT, Clancy JL, Thermann R, Martin DI, Hentze MW, et al. microRNA-mediated messenger RNA deadenylation contributes to translational repression in mammalian cells. PLoS One 2009; 4:e6783; PMID:19710908; http://dx.doi.org/10.1371/journal.pone.0006783.
100. Eulalio A, Huntzinger E, Nishihara T, Rehwinkel J, Fauser M, Izaurralde E. Deadenylation is a wide-spread effect of miRNA regulation. RNA 2009; 15:21-32; PMID:19029310; http://dx.doi.org/10.1261/rna.1399509.
101. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010; 466:835-40; PMID:20703300; http://dx.doi.org/10.1038/nature09267.
102. Nilsen TW. Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet 2007; 23:243-9; PMID:17368621; http://dx.doi.org/10.1016/j. tig.2007.02.011.
103. Liu J, Rivas FV, Wohlschlegel J, Yates JR 3rd, Parker R, Hannon GJ. A role for the P-body component GW182 in microRNA function. Nat Cell Biol 2005; 7:1261-6; PMID:16284623; http://dx.doi.org/10.1038/ncb1333.
104. Lian SL, Li S, Abadal GX, Pauley BA, Fritzler MJ, Chan EK. The C-terminal half of human Ago2 binds to multiple GW-rich regions of GW182 and requires GW182 to mediate silencing. RNA 2009; 15:804-13; PMID:19324964; http://dx.doi.org/10.1261/rna.1229409.
105. Ding XC, Grosshans H. Repression of C. elegans microRNA targets at the initiation level of translation requires GW182 proteins. EMBO J 2009; 28:213-22; PMID:19131968; http://dx.doi.org/10.1038/emboj.2008.275.
106. Fabian MR, Mathonnet G, Sundermeier T, Mathys H, Zipprich JT, Svitkin YV, et al. Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. Mol Cell 2009; 35:868-80; PMID:19716330; http://dx.doi.org/10. 1016/j.molcel.2009.08.004.
107. Braun JE, Huntzinger E, Fauser M, Izaurralde E. GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. Mol Cell 2011; 44:120-33; PMID:21981923; http://dx.doi.org/10.1016/j.molcel.2011.09.007.
108. Eulalio A, Huntzinger E, Izaurralde E. GW182 interaction with Argonaute is essential for miRNA-mediated translational repression and mRNA decay. Nat Struct Mol Biol 2008; 15:346-53; PMID:18345015; http://dx.doi.org/10.1038/nsmb. 1405.
109. Chekulaeva M, Mathys H, Zipprich JT, Attig J, Colic M, Parker R, et al. miRNA repression involves GW182-mediated recruitment of CCR4-NOT through conserved W-containing motifs. Nat Struct Mol Biol 2011; 18:1218-26; PMID:21984184; http://dx.doi.org/10.1038/nsmb.2166.
110. Su H, Meng S, Lu Y, Trombly MI, Chen J, Lin C, et al. Mammalian hyperplastic discs homolog EDD regulates miRNA-mediated gene silencing. Mol Cell 2011; 43:97-109; PMID:21726813; http://dx.doi.org/10.1016/j.molcel.2011.06.013.
111. Fabian MR, Cieplak MK, Frank F, Morita M, Green J, Srikumar T, et al. miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motifs that interact with CCR4-NOT. Nat Struct Mol Biol 2011; 18:1211-7; PMID:21984185; http://dx.doi.org/10.1038/nsmb.2149.
112. Yang Z, Jakymiw A, Wood MR, Eystathioy T, Rubin RL, Fritzler MJ, et al. GW182 is critical for the stability of GW bodies expressed during the cell cycle and cell proliferation. J Cell Sci 2004; 117:5567-78; PMID:15494374; http://dx.doi.org/10.1242/jcs.01477.
113. Jakymiw A, Lian S, Eystathioy T, Li S, Satoh M, Hamel JC, et al. Disruption of GW bodies impairs mammalian RNA interference. Nat Cell Biol 2005; 7:1267-74; PMID:16284622; http://dx.doi.org/10.1038/ncb1334.
114. Lian S, Jakymiw A, Eystathioy T, Hamel JC, Fritzler MJ, Chan EK. GW bodies, microRNAs and the cell cycle. Cell Cycle 2006; 5:242-5; PMID:16418578; http://dx.doi.org/10.4161/cc.5.3.2410.
115. Flemr M, Ma J, Schultz RM, Svoboda P. P-body loss is concomitant with formation of a messenger RNA storage domain in mouse oocytes. Biol Reprod 2010; 82:1008-17; PMID:20075394; http://dx.doi.org/10.1095/biolreprod.109.082057.
116. Eulalio A, Behm-Ansmant I, Schweizer D, Izaurralde E. P-body formation is a consequence, not the cause, of RNA-mediated gene silencing. Mol Cell Biol 2007; 27:3970-81; PMID:17403906; http://dx.doi.org/10.1128/MCB.00128-07.
117. Spassov DS, Jurecic R. The PUF family of RNA-binding proteins: does evolutionarily conserved structure equal conserved function? IUBMB Life 2003; 55:359-66; PMID:14584586; http://dx.doi.org/10.1080/15216540310001603093.
118. Miles WO, Tschöp K, Herr A, Ji JY, Dyson NJ. Pumilio facilitates miRNA regulation of the E2F3 oncogene. Genes Dev 2012; 26:356-68; PMID:22345517; http://dx.doi.org/10.1101/gad.182568.111.
119. Lin CC, Liu LZ, Addison JB, Wonderlin WF, Ivanov AV, Ruppert JM. A KLF4-miRNA-206 autoregulatory feedback loop can promote or inhibit protein translation depending upon cell context. Mol Cell Biol 2011; 31:2513-27; PMID:21518959; http://dx.doi.org/10.1128/MCB.01189-10.
120. Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J, et al. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 2008; 36:5391-404; PMID:18701644; http://dx.doi.org/10.1093/nar/gkn522.
121. Garnon J, Lachance C, Di Marco S, Hel Z, Marion D, Ruiz MC, et al. Fragile X-related protein FXR1P regulates proinflammatory cytokine tumor necrosis factor expression at the post-transcriptional level. J Biol Chem 2005; 280:5750-63; PMID:15548538; http://dx.doi.org/10.1074/jbc.M401988200.
122. Hornstein E, Tang H, Meyuhas O. Mitogenic and nutritional signals are transduced into translational efficiency of TOP mRNAs. Cold Spring Harb Symp Quant Biol 2001; 66:477-84; PMID:12762050; http://dx.doi.org/10.1101/sqb.2001. 66.477.
123. Ørom UA, Nielsen FC, Lund AH. MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 2008; 30:460-71; PMID:18498749; http://dx.doi.org/10.1016/j.molcel.2008.05.001.
124. Till S, Lejeune E, Thermann R, Bortfeld M, Hothorn M, Enderle D, et al. A conserved motif in Argonaute-interacting proteins mediates functional interactions through the Argonaute PIWI domain. Nat Struct Mol Biol 2007; 14:897-903; PMID:17891150; http://dx.doi.org/10.1038/nsmb1302.
125. Iwasaki S, Tomari Y. Argonaute-mediated translational repression (and activation). Fly (Austin) 2009; 3:204-6; PMID:19556851.
126. Siomi MC, Zhang Y, Siomi H, Dreyfuss G. Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Mol Cell Biol 1996; 16:3825-32; PMID:8668200.
127. Seal R, Temperley R, Wilusz J, Lightowlers RN, Chrzanowska-Lightowlers ZM. Serum-deprivation stimulates cap-binding by PARN at the expense of eIF4E, consistent with the observed decrease in mRNA stability. Nucleic Acids Res 2005; 33:376-87; PMID:15653638; http://dx.doi.org/10.1093/nar/gki169.
128. Roy AL, Chakrabarti D, Datta B, Hileman RE, Gupta NK. Natural mRNA is required for directing MettRNA(f) binding to 40S ribosomal subunits in animal cells: involvement of Co-eIF-2A in natural mRNA-directed initiation complex formation. Biochemistry 1988; 27:8203-9; PMID:3233204; http://dx.doi.org/10. 1021/bi00421a033.
129. Unhavaithaya Y, Hao Y, Beyret E, Yin H, Kuramochi-Miyagawa S, Nakano T, et al. MILI, a PIWI-interacting RNA-binding protein, is required for germ line stem cell self-renewal and appears to positively regulate translation. J Biol Chem 2009; 284:6507-19; PMID:19114715; http://dx.doi.org/10.1074/jbc.M809104200.
130. Jackson RJ, Hellen CU, Pestova TV. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 2010; 11:113-27; PMID:20094052; http://dx.doi.org/10.1038/nrm2838.
131. Hinnebusch AG. eIF3: a versatile scaffold for translation initiation complexes. Trends Biochem Sci 2006; 31:553-62; PMID:16920360; http://dx.doi.org/10.1016/j.tibs.2006.08.005.
132. Diederichs S, Jung S, Rothenberg SM, Smolen GA, Mlody BG, Haber DA. Coexpression of Argonaute-2 enhances RNA interference toward perfect match binding sites. Proc Natl Acad Sci U S A 2008; 105:9284-9; PMID:18591665; http://dx.doi.org/10.1073/pnas.0800803105.
133. Eiring AM, Harb JG, Neviani P, Garton C, Oaks JJ, Spizzo R, et al. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 2010; 140:652-65; PMID:20211135; http://dx.doi.org/10.1016/j.cell.2010.01.007.
134. Leung AK, Vyas S, Rood JE, Bhutkar A, Sharp PA, Chang P. Poly(ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm. Mol Cell 2011; 42:489-99; PMID:21596313; http://dx.doi.org/10.1016/j.molcel.2011.04.015.
135. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010; 465:1033-8; PMID:20577206; http://dx.doi.org/10.1038/ nature09144.
136. Cazalla D, Yario T, Steitz JA. Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science 2010; 328:1563-6; PMID:20558719; http://dx.doi.org/10.1126/science.1187197.
137. Ebert MS, Sharp PA. Emerging roles for natural microRNA sponges. Curr Biol 2010; 20:R858-61; PMID:20937476; http://dx.doi.org/10.1016/j.cub.2010.08. 052.
138. Meisner NC, Filipowicz W. Properties of the regulatory RNA-binding protein HuR and its role in controlling miRNA repression. Adv Exp Med Biol 2010; 700:106-23; PMID:21627034; http://dx.doi.org/10.1007/978-1-4419-7823-3-10.
139. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006; 125:1111-24; PMID:16777601; http://dx.doi.org/10.1016/j. cell.2006.04.031.
140. Srikantan S, Abdelmohsen K, Lee EK, Tominaga K, Subaran SS, Kuwano Y, et al. Translational control of TOP2A influences doxorubicin efficacy. Mol Cell Biol 2011; 31:3790-801; PMID:21768308; http://dx.doi.org/10.1128/MCB.05639-11.
141. Murphy AJ, Guyre PM, Pioli PA. Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages. J Immunol 2010; 184:5029-37; PMID:20351193; http://dx.doi.org/10. 4049/jimmunol.0903463.
142. Leung AK, Calabrese JM, Sharp PA. Quantitative analysis of Argonaute protein reveals microRNA-dependent localization to stress granules. Proc Natl Acad Sci U S A 2006; 103:18125-30; PMID:17116888; http://dx.doi.org/10.1073/ pnas.0608845103.
143. Wyman SK, Knouf EC, Parkin RK, Fritz BR, Lin DW, Dennis LM, et al. Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity. Genome Res 2011; 21:1450-61; PMID:21813625; http://dx.doi.org/10.1101/gr.118059.110.
144. Li J, Yang Z, Yu B, Liu J, Chen X. Methylation protects miRNAs and siRNAs from a 3′-end uridylation activity in Arabidopsis. Curr Biol 2005; 15:1501-7; PMID:16111943; http://dx.doi.org/10.1016/j.cub.2005.07.029.
145. Houbaviy HB, Murray MF, Sharp PA. Embryonic stem cell-specific MicroRNAs. Dev Cell 2003; 5:351-8; PMID:12919684; http://dx.doi.org/10.1016/S1534-5807(03) 00227-2.
146. Newman MA, Mani V, Hammond SM. Deep sequencing of microRNA precursors reveals extensive 3′ end modification. RNA 2011; 17:1795-803; PMID:21849429; http://dx.doi.org/10.1261/rna.2713611.
147. Burns DM, D'Ambrogio A, Nottrott S, Richter JD. CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation. Nature 2011; 473:105-8; PMID:21478871; http://dx.doi.org/10.1038/nature09908.
148. Katoh T, Sakaguchi Y, Miyauchi K, Suzuki T, Kashiwabara S, Baba T, et al. Selective stabilization of mammalian microRNAs by 3′ adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2. Genes Dev 2009; 23:433-8; PMID:19240131; http://dx.doi.org/10.1101/gad.1761509.
149. Jones MR, Quinton LJ, Blahna MT, Neilson JR, Fu S, Ivanov AR, et al. Zcchc11-dependent uridylation of microRNA directs cytokine expression. Nat Cell Biol 2009; 11:1157-63; PMID:19701194; http://dx.doi.org/10.1038/ncb1931.